Design and Synthesis of Redox Stable Analogues of Sunflower Trypsin Inhibitors (SFTI-1) on Solid Support, Potent Inhibitors of Matriptase

Sheng Jiang, Peng Li,§ Sheau-Ling Lee, Cheng Yong Lin, Ya-Qiu Long, Michael D. Johnson,* Robert B. Dickson,# and Peter P. Roller*;
Laboratory of Medicinal Chemistry, NCI, NIH, Frederick, Maryland 21702, and Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20057
Org. Lett., 2007, 9 (1), pp 9–12
DOI: 10.1021/ol0621497
Publication Date (Web): December 7, 2006
Copyright © 2007 American Chemical Society

 NCI, NIH.

,

 These authors contributed equally to the work.

,
§

 Current address:  Intra-Cellular Therapies, Inc., New York, 10032.

,

 Georgetown University Medical Center.

,

 Current address:  Shanghai Institute of Materia Medica, Shanghai 201203, China.

,
*

In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

,
#

 In memory of Dr Robert B. Dickson

, proll@helix.nih.gov, ; , johnsom@georgetown.edu

Abstract

Abstract Image

Matriptase is a member of the emerging class of type II transmembrane serine proteases. It was found that the sunflower trypsin inhibitor (SFTI-1), isolated from sunflower seeds, inhibits matriptase with a subnanomolar Ki of 0.92 nM. On the basis of this result, we designed and synthesized its proteolytically stable analogues, SFTI-2 and SFTI-3. SFTI-3 exhibited very good binding affinity to matriptase, and it was metabolically stable.

Tools

History

  • Published In Issue January 04, 2007
  • Received August 30, 2006

Recommend & Share

Related Content

Other ACS content by these authors: